Literature DB >> 19672555

Antibodies to PB1-F2 protein are induced in response to influenza A virus infection.

Ingrid Krejnusová1, Hana Gocníková, Magdaléna Bystrická, Hana Blaskovicová, Katarína Poláková, Jonathan Yewdell, Jack Bennink, Gustáv Russ.   

Abstract

PB1-F2 is a small influenza A virus (IAV) protein encoded by an alternative (+1) reading frame of the PB1 gene. While dispensable for IAV replication in cultured cells, PB1-F2 has been implicated in IAV pathogenicity. To better understand PB1-F2 expression in vivo and its immunogenicity, we analyzed anti-PB1-F2 antibodies (Abs) in sera of mice infected intranasally (i.n.) with A/PR/8/34 (H1N1) virus and human acute and convalescent sera collected from the influenza H3N2 winter 2003-2004 epidemic. We explored a number of methods for detecting anti-PB1-F2 Abs, finding that PB1-F2-specific Abs could clearly be detected via immunoprecipitation or immunofluorescence assays using both immune mouse and human convalescent sera. Importantly, paired human sera exhibited similar increases in HI titers and PB1-F2-specific Abs. This study indicates that PB1-F2 is expressed in sufficient quantities in mice and humans infected with IAV to elicit an Ab response, supporting the biological relevance of this intriguing accessory protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672555      PMCID: PMC2759409          DOI: 10.1007/s00705-009-0479-5

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  24 in total

1.  The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function.

Authors:  James S Gibbs; Daniela Malide; Felicita Hornung; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  PB1-F2 gene in influenza a viruses of different hemagglutinin subtype.

Authors:  H Pancuchárová; G Russ
Journal:  Acta Virol       Date:  2006       Impact factor: 1.162

3.  Characterization of the humoral immune response of experimentally infected and vaccinated pigs to swine influenza viral proteins.

Authors:  W-I Kim; W-H Wu; B Janke; K-J Yoon
Journal:  Arch Virol       Date:  2005-08-23       Impact factor: 2.574

4.  Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria.

Authors:  Hiroshi Yamada; Ritsu Chounan; Youichirou Higashi; Naoki Kurihara; Hiroshi Kido
Journal:  FEBS Lett       Date:  2004-12-17       Impact factor: 4.124

5.  Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals.

Authors:  B Lambrecht; M Steensels; S Van Borm; G Meulemans; T van den Berg
Journal:  Avian Dis       Date:  2007-03       Impact factor: 1.577

Review 6.  Influenza a virus PB1-F2 protein.

Authors:  H Gocnikova; G Russ
Journal:  Acta Virol       Date:  2007       Impact factor: 1.162

7.  Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1.

Authors:  Dmitriy Zamarin; Adolfo García-Sastre; Xiaoyao Xiao; Rong Wang; Peter Palese
Journal:  PLoS Pathog       Date:  2005-09-30       Impact factor: 6.823

Review 8.  The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages.

Authors:  J Robert Coleman
Journal:  Virol J       Date:  2007-01-15       Impact factor: 4.099

9.  Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.

Authors:  Surender Khurana; Amorsolo L Suguitan; Yonaira Rivera; Cameron P Simmons; Antonio Lanzavecchia; Federica Sallusto; Jody Manischewitz; Lisa R King; Kanta Subbarao; Hana Golding
Journal:  PLoS Med       Date:  2009-04-21       Impact factor: 11.069

10.  N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.

Authors:  Wanli Liu; Hua Li; Ying-Hua Chen
Journal:  FEMS Immunol Med Microbiol       Date:  2003-03-20
View more
  12 in total

Review 1.  Current knowledge on PB1-F2 of influenza A viruses.

Authors:  Andi Krumbholz; Anja Philipps; Hartmut Oehring; Katja Schwarzer; Annett Eitner; Peter Wutzler; Roland Zell
Journal:  Med Microbiol Immunol       Date:  2010-10-16       Impact factor: 3.402

2.  Genetic analysis of the PB1-F2 gene of equine influenza virus.

Authors:  Gang Lu; Wei Guo; Ting Qi; Jian Ma; Shihua Zhao; Zhige Tian; Jialiang Pan; Chao Zhu; Xiaojun Wang; Wenhua Xiang
Journal:  Virus Genes       Date:  2013-06-19       Impact factor: 2.332

3.  PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology.

Authors:  Julie L McAuley; Jerry E Chipuk; Kelli L Boyd; Nick Van De Velde; Douglas R Green; Jonathan A McCullers
Journal:  PLoS Pathog       Date:  2010-07-22       Impact factor: 6.823

4.  High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.

Authors:  Kelvin K W To; Anna J X Zhang; Ivan F N Hung; Ting Xu; Whitney C T Ip; Rebecca T Y Wong; Joseph C K Ng; Jasper F W Chan; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2012-05-09

Review 5.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

6.  Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics.

Authors:  Amber M Smith; Frederick R Adler; Julie L McAuley; Ryan N Gutenkunst; Ruy M Ribeiro; Jonathan A McCullers; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2011-02-17       Impact factor: 4.475

7.  The ubiquitination of the influenza A virus PB1-F2 protein is crucial for its biological function.

Authors:  Ivan Košík; Margaréta Práznovská; Martina Košíková; Zuzana Bobišová; Jaroslav Hollý; Eva Varečková; František Kostolanský; Gustáv Russ
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

8.  Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans.

Authors:  Jiwon Jung; Sophia T Mundle; Irina V Ustyugova; Andrew P Horton; Daniel R Boutz; Svetlana Pougatcheva; Ponraj Prabakaran; Jonathan R McDaniel; Gregory R King; Daechan Park; Maria D Person; Congxi Ye; Bing Tan; Yuri Tanno; Jin Eyun Kim; Nicholas C Curtis; Joshua DiNapoli; Simon Delagrave; Ted M Ross; Gregory C Ippolito; Harry Kleanthous; Jiwon Lee; George Georgiou
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

Review 9.  B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.

Authors:  Jenna J Guthmiller; Henry A Utset; Patrick C Wilson
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

10.  Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design.

Authors:  Denise A Kaminski; F Eun-Hyung Lee
Journal:  Front Immunol       Date:  2011-12-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.